Holomeric estrogen receptor (ER) prepared from ovariectomized mouse uteri displays heterogeneous electrophoretic mobility when analyzed by NaDodSO4/PAGE. binding to the 65-kDa peptide was predominant. The ERn doublet displays a time dependency after estrogen administration with maximal amounts occurring in a bimodal fashion at 1 and 8 hr.
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Steroid hormones exert some of their actions in target tissues through a specific receptor mechanism (1) . Although the precise molecular mechanisms of action are not well understood, the generally accepted hypothesis is that the hormone binds to a specific receptor protein. This binding causes a conformational change in the receptor that produces a nuclear-residing form with increased affinity for DNA. This hormone-receptor complex then interacts with specific DNA and chromatin sites, causing modulation of gene expression for certain proteins. A number of reports have described the molecular characterization of the estrogen protein including gross physical determination of molecular weight and pI (2) , kinetic data on hormone binding (3), amino acid sequences (4) , and the DNA coding region sequence for the receptor protein (5) . In addition, intracellular receptor distributions within uterine tissue after estrogen treatment have been reported for the mouse (6) and the rat (7) . Recent studies by Auricchio and co-workers (8) have suggested that phosphorylation/dephosphorylation of the receptor protein may be important in ligand binding activity and subsequent processing. The intracellular location of the specific kinase and phosphatase enzyme has been elucidated (9) . Nonetheless, a paucity of data exists with regard to the actual regulation of receptor protein activity as directly induced by the hormone. Recent reports (10, 11) have suggested the phosphorylation of tyrosines as a possible regulatory point; however, the relationship between this phenomenon and hormonal activation of receptor has not been established conclusively (12) . Other reports indicate that, in the case of the estrogen receptor (ER), estradiol binding to the receptor directly influences receptor affinity for nonspecific nuclear binding sites (13) , mechanistically theorized as a change in receptor conformation. However, it has not been shown that ligands of various agonistic potencies cause altered conformational changes in the receptor, as would be necessary to produce differing hormonal actions.
Here we report the description of nuclear-specific heterogeneous forms of ER isolated from mouse uterine tissue. These forms are detectable by differences in mobility under modified NaDodSO4/PAGE conditions. The proportions of the receptor forms are dependent on the specific hormone administered. After estrogen treatment the receptor forms demonstrate an alteration in a temporal pattern that may play a role in the mechanism of hormone receptor action. At the time of use, uteri were placed in ice-cold TEGM-P buffer [10 mM Tris'HCI/1.5 mM EDTA/10% (vol/vol) glycerol/3 mM MgCl2/3 mM EGTA containing leupeptin, antipain, soybean trypsin inhibitor, and chymostatin at 50 ,4g of each per ml (pH 7.6 at 250C)]. The tissue was processed as previously described (14) to give a washed 1000 x g pellet (nuclei) and a 105,000 x g supernatant (cytosol) for use in NaDodSO4/PAGE and receptor binding experiments.
MATERIALS AND METHODS
Steroids. 17p8-[2,4,6,7-3H]Estradiol (110 Ci/mmol; 1 Ci = 37 GBq) was purchased from Du Pont-New England Nuclear and brought to >98% radiochemical purity by thin-layer chromatography (14 
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Sample Preparation for NaDodSO4/PAGE. Nuclear samples containing 150 Ag of DNA in a volume of 80 A.l of TEGM-P buffer were brought to a NaDodSO4 concentration of 5% (wt/vol) and the salt concentration was increased to 0.4 M NaCl. The sample was heated to 100TC for 2 min, diluted with 30 p.l of deionized water, and then clarified by centrifugation at 200,000 x g at 30'C for 110 min. The resulting supernatant was removed and diluted with an equal volume of deionized H20. Finally, the sample was precipitated by the addition of 4 vol of acetone at -20'C followed by incubation at -700C for 30 min. The protein precipitate was collected by centrifugation at 10,000 x g at 40C for 10 min, and the resulting pellet was suspended in 10 A.l of 10% (wt/vol) NaDodSO4 plus 15 1.l of 2x sample buffer [78 mM Tris-HCI/2.2% NaDodSO4/11% (wt/vol) sucrose/0.002% bromophenyl blue, pH 6.8] and stored at -70'C until the day of electrophoresis.
Cytosolic samples were precipitated directly by addition of acetone and processed identically to the nuclear samples commencing at the step following the acetone precipitation. Partially purified ERG, the isolation of which has been reported (15) , was prepared in an identical fashion to cytosol with the exception that 150 ,ug of bovine insulin (Collaborative Research, Waltham, MA) was included as a carrier protein.
The '4C-methylated protein mixture used as molecular weight markers for gels analyzed by immunochemical detection or by fluorography was obtained from Amersham. Amounts loaded per lane ranged from 7.5 nCi (total radioactivity) for gels to be analyzed by fluorography (corresponding to 0.833 nCi for each of six proteins) to 25 nCi for gels analyzed by immunochemical detection followed by autoradiography.
Coomassie brilliant blue-prestained bovine serum albumin and lactate dehydrogenase molecular mass standards were purchased from Diversified Biotech (Newton Center, MA). NaDodSO4/PAGE. Reagents for electrophoresis were obtained from Bio-Rad. NaDodSO4/polyacrylamide slab gel electrophoresis was carried out according to O'Farrell (16) with the exception of using an 8% resolution gel with a 3% acrylamide stacking gel. Sample loading was maximized to 250 jig of protein, or 120 ,ug of DNA, per lane. All samples were treated prior to loading with 48 mM dithiothreitol, then heated at 100°C for 2 min, and exposed to 0.13 M iodoacetamide/0.07 M Tris base to block available sulfhydryl groups. Polyacrylamide gels were stained with silver according to a modified method of Morrissey as reported (17) .
Immunoblotting and Immunochemical Detection. Bilateral diffusion blotting of proteins to nitrocellulose was carried out as described (17) . Pure nitrocellulose of 0.20-,um pore size was purchased from Schleicher & Schuell. Immunochemical detection of ER from mouse uteri was performed as reported (15 molecular properties between the two peptides. As shown in Fig. 3A (lanes 1 and 2) , both doublet bands bound ligand in a specific manner as determined by fluorography of ER. Fig. 1 following administration However, it should be noted that the lower band bound ligand to a greater extent, since immunodetection should equal amounts of both bands in the respective sample (lanes 3 and 4).
The presence of the DNA binding domain for the ER was also investigated, and the results are shown in Fig. 3B . The anti-ER monoclonal antibody H-226, which recognizes an epitope near or in the DNA binding domain (21) , detected both bands of the doublet. Hence, the DNA binding domain is present in both bands of the ERn doublet (lanes 4 and 5).
To determine whether the relative amounts of the ERn change during hormone stimulation, the receptor pattern was analyzed at different times following hormone treatment. The profile is shown in Fig. 4A , where different forms of ERn with relative mobilities corresponding to molecular masses of 65 and 54 kDa are seen. These results are consistent with other investigators' studies of ER from sources such as MCF-7 cells (22) and are thought to represent a 65-kDa holoreceptor and two proteolytic fragments of lower molecular mass (15, 22) . The appearance of the doublet was clearly evident and dependent on the hormonal state of the tissue, with maximal amounts of the two peptides occurring by 1 hr after injection of estradiol (Fig. 4A, lane 4) . Analysis of the autoradiograph by laser densitometric scanning (Fig. 4B) (22) have also reported similar fragments of ER in both the rat uterus and MCF-7 cultured cell models and have concluded that their existence is artifactual since high concentrations ofleupeptin eliminated their formation. In our studies, a similar result was evident for mouse uterine ER in that buffers containing protease inhibitors reduce the production of these smaller fragments (15) .
A plausible explanation for the existence of the ER, doublet, therefore, is simply the proteolytic removal of =15 amino acids from the upper band during the isolation and processing of the sample. This degradation may be artifactual or may be a normal processing mechanism present in the cells; the data, however, support the latter based on the following observations. First, the protease inhibitors that inhibited the formation of the 54-and 37-kDa fragments did not prevent the formation of the ERn doublet. Second, the localization of the doublet is exclusively nuclear, contrary to the ubiquitous appearance of the previously mentioned smaller fragments. Third, homogenization of tissue directly in a buffer containing 0.2% NaDodSO4 eliminated the formation of the smaller fragments but did not alter the formation of the 65-kDa doublet (data not shown). This result eliminates the possibility of in vitro artifactual degradation but has no bearing on the occurrence of in vivo proteolytic processing.
Alternatively, a phosphorylative mechanism could be hypothesized for the production of the ERn doublet. Evidence of steroid receptor phosphorylation has been demonstrated for the glucocorticoid (23) , androgen (24) , and progesterone (25) receptors. Additionally, Aurrichio et al. (9) have reported the phosphorylation of the ER from calf uteri and have localized the involved phosphatase in the cytosol and the responsible kinase in the nuclei. A change in molecular mass as a steroid receptor protein is phosphorylated has been reported by Horwitz et al. (26) for the progesterone receptor; the existence of the upper band of the ERn, which has a greater molecular mass than any other ER, whether nuclear or cytosolic, would be consistent as being a phosphorylated species. In addition, the localization of the doublet exclusively to the nucleus would be appropriate considering the kinase location reported by Aurrichio et al. (9) . A possible role for this modified ERn form is not clear; however, it appears to be associated with the salt-resistant fraction, which has been suggested to be the tightly bound chromatin sites of ER nuclear interactions (7) or the site of nuclear matrix ER (27) . These results suggest that the ERn is changed to this modified form to specifically interact with these nuclear sites.
In conclusion, the mechanism for the formation of the ERn doublet is not clear, but molecular modification occurs that may involve phosphorylation;t however, other protein modifications such as glycosylation and acylation have not been ruled out. Regardless of the manner of ERn modification, a nuclear specific hormone-directed mechanism exists that creates ERn with two different electrophoretic mobilities.
Since this phenomenon is responsive to the estrogenic potency of the bound ligand, is associated with specific nuclear fractions, and fluctuates during tissue stimulation, it is important to the mechanism of steroid hormone action. 
